Contemporary treatment of small-vessel disease

Journal of Invasive Cardiology

Volumn 16, Issue 8, 2004, Pages 417-418

  Hermiller Jr , James B ^a  

^a ST VINCENT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ANGIOCARDIOGRAPHY; BLOOD VESSEL DIAMETER; CLINICAL TRIAL; CORONARY ARTERY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETES MELLITUS; DRUG ELUTING STENT; HEART MUSCLE REVASCULARIZATION; HUMAN; INTIMA; INTRAVASCULAR ULTRASOUND; NOTE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY STENOSIS; CORONARY VESSELS; DRUG DELIVERY SYSTEMS; HUMANS; PACLITAXEL; SIROLIMUS; STENTS;

EID: 4143096053     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (15)

1. Schunkert H, Harrell L, Palacios IF. Implications of small reference vessel diameter in patients undergoing percutaneous coronary revascularization. J Am Coll Cardiol 1999;34:40-48.
2. Ellis SG, Vandormael MG, Cowley MJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation 1990;82:1193-1202.
3. Hirshfield JW, Schwartz JS, Jugo R, et al. Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. J Am Coll Cardiol 1991;18:647-656.
4. Boaurassa MG, Lesperance J, Eastwood C, et al. Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1991;18:368-376.
5. Foley DP, Melkert R, Serruys PW. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty. Circulation 1994;90:1239-1251.
6. Lau KW, Hung JS, Sigwart U. The current status of stent placement in small coronary arteries < 3.0 mm in diameter. J Invas Cardiol 2004;16:411-416.
7. Moussa I, Kobayashi Y, Adamian M, et al. Characteristics of patients with a large discrepancy in coronary artery diameter between quantitative angiography and intravascular ultrasound. Am J Cardiol 2001;88:294-296.
8. Schuhlen H, Kastrati A, Dirschinger J, et al. Intracoronary stenting and risk for major adverse cardiac events during the first month. Circulation 1998;98:104-111.
9. Moreno R, Fernandez C, Hernandez-Antolin R, et al. The benefit of coronary stenting in small vessels is dependent on reference vessel diameter: Results from a meta-analysis of 11 randomized trials. J Am Coll Cardiol 2004;43:58A.
10. Foley DP, Melkert R, Serruys PW. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty. Circulation 1994;90:1239-1251.
11. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
12. Schampaert E, Cohen EA, Schluter M, et al. for the C-SIRIUS Investigators. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 2004;43:1110-1115.
13. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Eng J Med 2004;350:221-231.
14. Stone GW, Ellis SG, O'Shaughnessy C, et al. Reduction in late loss and restenosis in patients with small vessels treated with the slow rate-release, polymer-based paclitaxel-eluting stent: Results from TAXUS-IV. J Am Coll Cardiol 2005;43:87A.
15. Greenberg D, Bakhai A, Cohen DJ. Can we afford to eliminate restenosis? Can we afford not to? J Am Coll Cardiol 2004;43:513-518.